In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Solid Biosciences Inc (NASDAQ: SLDB) closed the day trading at $5.00 up 3.09% from the previous closing price of $4.85. In other words, the price has increased by $3.09 from its previous closing price. On the day, 0.57 million shares were traded. SLDB stock price reached its highest trading level at $5.11 during the session, while it also had its lowest trading level at $4.61.
Ratios:
For a better understanding of SLDB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.85 and its Current Ratio is at 7.85. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on July 15, 2024, Upgraded its rating to Overweight and sets its target price to $15 from $10 previously.
On June 24, 2024, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform but kept the price unchanged to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 21 ’24 when Brooks Gabriel sold 2,923 shares for $6.50 per share. The transaction valued at 19,000 led to the insider holds 10,979 shares of the business.
Kahn Clare bought 1,100 shares of SLDB for $8,442 on Jun 07 ’24. The Director now owns 1,100 shares after completing the transaction at $7.67 per share. On May 02 ’24, another insider, Ganot Ilan, who serves as the Director of the company, sold 462 shares for $10.33 each. As a result, the insider received 4,772 and left with 9,507 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLDB now has a Market Capitalization of 199772992 and an Enterprise Value of 47381844.
Stock Price History:
The Beta on a monthly basis for SLDB is 2.01, which has changed by 1.0208333 over the last 52 weeks, in comparison to a change of 0.2936039 over the same period for the S&P500. Over the past 52 weeks, SLDB has reached a high of $15.05, while it has fallen to a 52-week low of $2.21. The 50-Day Moving Average of the stock is -22.76%, while the 200-Day Moving Average is calculated to be -41.03%.
Shares Statistics:
Over the past 3-months, SLDB traded about 268.96K shares per day on average, while over the past 10 days, SLDB traded about 266670 shares per day. A total of 39.95M shares are outstanding, with a floating share count of 32.57M. Insiders hold about 18.48% of the company’s shares, while institutions hold 79.79% stake in the company. Shares short for SLDB as of 1730332800 were 1482450 with a Short Ratio of 5.51, compared to 1727654400 on 1729710. Therefore, it implies a Short% of Shares Outstanding of 1482450 and a Short% of Float of 7.8.
